![Torben Nissen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Torben Nissen
Fondatore presso
Flagship Labs 84, Inc.
Profilo
Dr. Torben S.
Nissen is a Chairman & Chief Executive Officer at Repertoire Immune Medicines, Inc., a Chairman at Etiome, Inc., an Executive Partner at Flagship Pioneering, Inc. and a Chief Executive Officer, Treasurer & Director at Torque Therapeutics, Inc. He is on the Board of Directors at Torque Therapeutics, Inc. Dr. Nissen was previously employed as an Independent Director by Axcella Health, Inc., a President by VL26, INC., a Head-Worldwide Research & Development by Pfizer Inc., a Chief Operating Officer & Executive Director by Centers for Therapeutic Innovation, a Chief Operating Officer by Ascendis Pharma A/S, a Managing Director by Maxygen, Inc., a President by Moksha8 Pharmaceuticals, Inc., and a Principal by Novo Nordisk A/S.
He also served on the board at Ring Therapeutics, Inc. He received his graduate degree from Technical University of Denmark and a doctorate degree from Technical University of Denmark.
Posizioni attive di Torben Nissen
| Società | Posizione | Inizio |
|---|---|---|
Flagship Pioneering, Inc.
 Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Investitore di Private Equity | 01/11/2016 |
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Amministratore Delegato | 01/01/2024 |
Flagship Labs 84, Inc.
 Flagship Labs 84, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines | Fondatore | 01/01/2021 |
Torque Therapeutics, Inc.
 Torque Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies to address cancers | Amministratore Delegato | - |
Precedenti posizioni note di Torben Nissen
| Società | Posizione | Fine |
|---|---|---|
| AXCA HEALPAR | Direttore/Membro del Consiglio | 01/11/2023 |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops transforming commensal viruses therapies | Direttore/Membro del Consiglio | 01/12/2021 |
| RUBIUS THERAPEUTICS | Presidente | 24/07/2019 |
| PFIZER INC. | Corporate Officer/Principal | 01/11/2016 |
Centers for Therapeutic Innovation | Direttore operativo | 01/01/2014 |
Formazione di Torben Nissen
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
80
Relazioni di 1° grado
14
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 14 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops directed molecular evolution technology | Commercial Services |
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Moksha8 Pharmaceuticals, Inc.
 Moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes medicines | Health Technology |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
Technical University of Denmark
 Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascendis Pharma A/S
 Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
Centers for Therapeutic Innovation | |
Axcella Health, Inc.
 Axcella Health, Inc. BiotechnologyHealth Technology Provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology | Health Technology |
Torque Therapeutics, Inc.
Torque Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies to address cancers | Health Technology |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Develops red cell therapeutics for cancer treatment | Health Technology |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops transforming commensal viruses therapies | Health Technology |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Health Technology |
Flagship Labs 84, Inc.
Flagship Labs 84, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines | Health Technology |
